Bortezomib

Overview

4.5 out of 5 (19 Reviews)

Credits

1.00

Pharmacology Credits

1.00

Post Assessment Questions

5

Start Date

1 Sep 2023

Last Review Date

4 Sep 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Bortezomib is FDA-approved for use in the initial treatment of multiple myeloma in combination with cyclophosphamide and dexamethasone. It is also FDA-approved for use in the treatment of multiple myeloma in individuals who previously responded to bortezomib and relapsed at least six months after the completion of the prior treatment. Also, it is FDA-approved for use in the treatment of mantle cell lymphoma in individuals who have received at least one previous first-line treatment. This activity will review the mechanism of action, adverse event profile, toxicity, dosing, pharmacodynamics, and monitoring pertinent for members of the interprofessional team for the treatment of patients with multiple myeloma.

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Summarize the mechanism of action of bortezomib.
  • Identify the approved indications for bortezomib.
  • Review the adverse events of bortezomib.
  • Outline interprofessional team strategies for improving care coordination and communication to advance bortezomib use and improve outcomes in cancer treatment.
  • Outline the indications of Bortezomib

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Nurse Practitioners: StatPearls designates this activity for 1.00 ANCC contact hour(s), which includes 1.00 hour(s) of pharmacology. NPs should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Mike G. on 9/3/2021

Harry A. on 10/17/2021

Anne C. on 3/28/2022

Diane L. on 6/2/2022

Shannon j. on 7/25/2022

Michael R. on 4/22/2023

Samantha P. on 6/29/2023

Michele N. on 7/8/2023

Li Mei L. on 8/19/2023

david s. on 9/12/2023

Suzanne H. on 9/18/2023

Nelson R. on 9/28/2023

Peter S. on 10/30/2023

Everett M. on 11/22/2023

Wassim E. on 12/18/2023

shazia z. on 1/27/2024

Kelly K. on 2/13/2024

Redentor R. on 2/28/2024

Mark A. on 3/23/2024

Unlimited Nurse Practitioner CE

Stay up to date on the latest medical knowledge with 6675 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7930 hours of CE.

Single Activity

Take this single activity

$49 1 activity

6 Month Unlimited Nurse Practitioner CE

Access to all the Unlimited Nurse Practitioner CE activities in all specialties.

$379 per half year per user

1 Year Unlimited Nurse Practitioner CE

Access to all the Unlimited Nurse Practitioner CE activities in all specialties.

$579 per 1 year per user